Avastin effective at delaying brain tumor progression in recurrent disease

(SEATTLE) - The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance.

Read the whole article on Science Blog

More from Science Blog